These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16043398)

  • 21. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies.
    Cenacchi G; Papa V; Fanin M; Pegoraro E; Angelini C
    J Neurol; 2011 May; 258(5):746-52. PubMed ID: 21088848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Musk-antibody positive myasthenia gravis presenting with isolated neck extensor weakness.
    Casasnovas C; Povedano M; Jaumà S; Montero J; Martínez-Matos JA
    Neuromuscul Disord; 2007 Jul; 17(7):544-6. PubMed ID: 17533129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.
    Zhou L; McConville J; Chaudhry V; Adams RN; Skolasky RL; Vincent A; Drachman DB
    Muscle Nerve; 2004 Jul; 30(1):55-60. PubMed ID: 15221879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myopathy, muscle atrophy and tongue lipid composition in MuSK myasthenia gravis.
    Nikolić AV; Bačić GG; Daković MŽ; Lavrnić SĐ; Rakočević Stojanović VM; Basta IZ; Lavrnić DV
    Acta Neurol Belg; 2015 Sep; 115(3):361-5. PubMed ID: 25253293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
    Koneczny I; Cossins J; Vincent A
    J Anat; 2014 Jan; 224(1):29-35. PubMed ID: 23458718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China.
    Yang L; Maxwell S; Leite MI; Waters P; Clover L; Fan X; Zhang D; Yang C; Beeson D; Vincent A
    J Neurol Sci; 2011 Feb; 301(1-2):71-6. PubMed ID: 21131008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
    Sanadze AG; Sidnev DV; Karganov MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are MuSK antibodies the primary cause of myasthenic symptoms?
    Selcen D; Fukuda T; Shen XM; Engel AG
    Neurology; 2004 Jun; 62(11):1945-50. PubMed ID: 15184594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
    Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G
    Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete stable remission and autoantibody specificity in myasthenia gravis.
    Baggi F; Andreetta F; Maggi L; Confalonieri P; Morandi L; Salerno F; Bernasconi P; Montomoli C; Barberis M; Mantegazza R; Antozzi C
    Neurology; 2013 Jan; 80(2):188-95. PubMed ID: 23255823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis.
    Kwon YN; Woodhall M; Sung JJ; Kim KK; Lim YM; Kim H; Kim JE; Baek SH; Kim BJ; Park JS; Seok HY; Kim DS; Kwon O; Park KH; Sohn E; Bae JS; Yoon BN; Kim NH; Ahn SW; Choi K; Oh J; Park HJ; Shin KJ; Lee S; Park J; Kim SH; Seok JI; Bae DW; An JY; Joo IS; Choi SJ; Nam TS; Kim S; Park KJ; Kwon KH; Waters P; Hong YH
    J Neurol; 2023 Mar; 270(3):1478-1486. PubMed ID: 36396811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myasthenia gravis patients with anti-MuSK antibodies.
    Zagar M; Vranjes D; Sostarko M; Vogrinc Z; Bilić E; Trbojević Cepe M
    Coll Antropol; 2009 Dec; 33(4):1151-4. PubMed ID: 20102061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Seronegative myasthenia and myasthenia gravis with anti-MuSK antibody: a retrospective study of 20 cases].
    Aubert S; Salort-Campana E; Franques J; Uzenot D; Pouget J
    Rev Neurol (Paris); 2009 Nov; 165(11):901-10. PubMed ID: 19327804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Seronegative myasthenia gravis].
    Gajdos P
    Rev Neurol (Paris); 2004 Feb; 160(2):159-62. PubMed ID: 15034472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies in Japanese patients with ocular myasthenia gravis.
    Nagaishi A; Narita T; Woodhall M; Jacobson L; Waters P; Irani SR; Vincent A; Matsuo H
    Muscle Nerve; 2021 Feb; 63(2):262-267. PubMed ID: 33094484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.